In 1993 was created Oracle Investment Management Inc., which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Greenwich.
The overall number of key employees were 1.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Oracle Investment Management Inc., startups are often financed by US Department of Energy, U.S. Department of Agriculture, Matthew W. Strobeck. The meaningful sponsors for the fund in investment in the same round are Jack Schuler, Westwood Holdings Group, Venrock. In the next rounds fund is usually obtained by Oracle, M12, Jack Schuler.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. This Oracle Investment Management Inc. works on 31 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2003. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity.
Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biolase, Concentric Analgesics, Vermillion. We can highlight the next thriving fund investment areas, such as Developer Tools, Chemical. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
Fund Name | Location |
American International Group | New York, New York, United States |
Edventures | Boise, Idaho, United States |
Georgia State University | Atlanta, Georgia, United States |
Hangzhou Meisheng Aibi Wenhua Fazhan Youxian Gongsi | China, Hangzhou, Zhejiang |
INTCO Medical | China, Shandong, Zibo |
Kairos Angels | - |
Kangmei Pharmaceutical | China, Guangdong Province, Huizhou |
Macomb Community College | Michigan, United States, Warren |
MassChallenge Switzerland | Renens, Switzerland, Vaud |
MicroPort Scientific | - |
Mountain Trail Investments | California, Los Angeles, United States |
Owens Corning | Ohio, Toledo, United States |
Slingshot Accelerator | Australia, New South Wales, Sydney |
Steel City Capital Funding | - |
The Hina Group | California, San Francisco, United States |
Toscafund Asset Management | England, London, United Kingdom |
Transdev | France, Ile-de-France, Issy-les-moulineaux |
Van Wickle Ventures | Providence, Rhode Island, United States |
Weizhong Xiang Jijin | China, Jiangsu, Nanjing |
Wellington Underwriting | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Core Starters | $1M | 08 Nov 2021 | - | ||
Pyramid Biosciences | $33M | 15 Oct 2021 | Massachusetts, United States | ||
Concentric Analgesics | $77M | 22 May 2019 | San Francisco, California, United States | ||
WhiteSource | $1M | 01 Mar 2013 | Tel Aviv District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Core Starters | $1M | 08 Nov 2021 | - | ||
Pyramid Biosciences | $33M | 15 Oct 2021 | Massachusetts, United States | ||
Concentric Analgesics | $77M | 22 May 2019 | San Francisco, California, United States | ||
WhiteSource | $1M | 01 Mar 2013 | Tel Aviv District |